Form 4: Enova International CEO David Fisher Reports Stock Option Exercises and Sales
SEC Form 4 Filing
Enova International's CEO, David Fisher, reports exercising stock options and selling shares on May 7, 2024, according to a Form 4 filing with the SEC.
Summary
- David Fisher, CEO of Enova International, Inc., filed a Form 4 with the SEC on May 9, 2024.
- The filing reports transactions that occurred on May 7, 2024, involving the exercise of stock options and the sale of common stock.
- Fisher exercised 8,124 stock options at a price of $20.85 per share and sold the resulting shares at a weighted average price of $62.9055.
- Additionally, he exercised 11,876 stock options at a price of $23.96 per share and sold the resulting shares at a weighted average price of $62.5927.
- Following these transactions, Fisher directly owns 461,439 shares of Enova International.
- He also holds options to purchase 26,219 shares that will vest in one-third increments on May 8, 2025, May 8, 2026, and May 8, 2027.
- The filing also includes a Power of Attorney, granting Sean Rahilly, Joanna Bartold, and Izabela Komaniecki the authority to act on Fisher's behalf in matters related to SEC filings.
Sentiment
Score: 5
Explanation: This is a routine filing related to stock option exercises and sales by the CEO. It doesn't inherently indicate positive or negative sentiment, but rather reflects standard executive compensation practices.
Industry Context
Executive stock transactions are routinely monitored by investors as they can provide insights into management's perspective on the company's valuation and future prospects. Option exercises and sales are a normal part of executive compensation.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in the number of outstanding shares.
- The filing ensures transparency for stakeholders regarding executive compensation and stock ownership.
Key Dates
| Date | Description |
|---|---|
| 02/13/2018 | Date of stock option award related to unexercised options. |
| 02/12/2019 | Date of stock option award related to unexercised options. |
| 02/13/2019 | First vesting date for 2018 stock options. |
| 02/12/2020 | First vesting date for 2019 stock options. |
| 02/13/2020 | Second vesting date for 2018 stock options. |
| 02/12/2021 | Second vesting date for 2019 stock options. |
| 02/13/2021 | Third vesting date for 2018 stock options. |
| 02/12/2022 | Third vesting date for 2019 stock options. |
| 02/13/2025 | Expiration date for Non-Qualified Stock Option (right to buy) with limited SAR. |
| 02/12/2026 | Expiration date for Non-Qualified Stock Option (right to buy) with limited SAR. |
| 05/07/2024 | Date of stock option exercise and share sales. |
| 05/08/2024 | Date of new stock option grant. |
| 05/08/2025 | First vesting date for new stock options. |
| 05/08/2026 | Second vesting date for new stock options. |
| 05/08/2027 | Third vesting date for new stock options. |
| 05/08/2031 | Expiration date for new stock options. |
| 05/09/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.